Immunomodulating properties of protein hydrolysates for application in cow's milk allergy
Cow's milk proteins cause allergic symptoms in 2–3% of all infants. In these individuals, the tolerogenic state of the intestinal immune system is broken, which can lead to sensitization against antigens and eventually to allergic responses. Although a true treatment for food allergy is not ava...
Saved in:
Published in | Pediatric allergy and immunology Vol. 26; no. 3; pp. 206 - 217 |
---|---|
Main Authors | , , , , |
Format | Journal Article |
Language | English |
Published |
England
Blackwell Publishing Ltd
01.05.2015
Wiley Subscription Services, Inc |
Subjects | |
Online Access | Get full text |
ISSN | 0905-6157 1399-3038 1399-3038 |
DOI | 10.1111/pai.12354 |
Cover
Loading…
Abstract | Cow's milk proteins cause allergic symptoms in 2–3% of all infants. In these individuals, the tolerogenic state of the intestinal immune system is broken, which can lead to sensitization against antigens and eventually to allergic responses. Although a true treatment for food allergy is not available, symptoms can be avoided by providing the infants with hydrolyzed proteins. Hydrolyzed proteins are proteins that are enzymatically degraded. They lack typical allergenic IgE‐binding epitopes but are also thought to play a pertinent role in other mechanisms inducing hypoallergenic effects. This review discusses the mechanisms and evidence for immunomodulating properties of cow's milk hydrolysates. Hydrolysates are found to strengthen the epithelial barrier, modulate T‐cell differentiation, and decrease inflammation. Some studies suggest a role for hydrolysates in manipulating pathogen recognition receptors signaling as underlying mechanism. Peptides from hydrolysates have been shown to bind to TLR2 and TLR4 and influence cytokine production in epithelial cells and macrophages. Current insight suggests that hydrolysates may actively participate in modulating the immune responses in subjects with cow's milk allergy and those at risk to develop cow's milk allergy. However, more research is required to design effective and reproducible means to develop targeting strategies to modulate the immune response. |
---|---|
AbstractList | Cow's milk proteins cause allergic symptoms in 2-3% of all infants. In these individuals, the tolerogenic state of the intestinal immune system is broken, which can lead to sensitization against antigens and eventually to allergic responses. Although a true treatment for food allergy is not available, symptoms can be avoided by providing the infants with hydrolyzed proteins. Hydrolyzed proteins are proteins that are enzymatically degraded. They lack typical allergenic IgE-binding epitopes but are also thought to play a pertinent role in other mechanisms inducing hypoallergenic effects. This review discusses the mechanisms and evidence for immunomodulating properties of cow's milk hydrolysates. Hydrolysates are found to strengthen the epithelial barrier, modulate T-cell differentiation, and decrease inflammation. Some studies suggest a role for hydrolysates in manipulating pathogen recognition receptors signaling as underlying mechanism. Peptides from hydrolysates have been shown to bind to TLR2 and TLR4 and influence cytokine production in epithelial cells and macrophages. Current insight suggests that hydrolysates may actively participate in modulating the immune responses in subjects with cow's milk allergy and those at risk to develop cow's milk allergy. However, more research is required to design effective and reproducible means to develop targeting strategies to modulate the immune response.Cow's milk proteins cause allergic symptoms in 2-3% of all infants. In these individuals, the tolerogenic state of the intestinal immune system is broken, which can lead to sensitization against antigens and eventually to allergic responses. Although a true treatment for food allergy is not available, symptoms can be avoided by providing the infants with hydrolyzed proteins. Hydrolyzed proteins are proteins that are enzymatically degraded. They lack typical allergenic IgE-binding epitopes but are also thought to play a pertinent role in other mechanisms inducing hypoallergenic effects. This review discusses the mechanisms and evidence for immunomodulating properties of cow's milk hydrolysates. Hydrolysates are found to strengthen the epithelial barrier, modulate T-cell differentiation, and decrease inflammation. Some studies suggest a role for hydrolysates in manipulating pathogen recognition receptors signaling as underlying mechanism. Peptides from hydrolysates have been shown to bind to TLR2 and TLR4 and influence cytokine production in epithelial cells and macrophages. Current insight suggests that hydrolysates may actively participate in modulating the immune responses in subjects with cow's milk allergy and those at risk to develop cow's milk allergy. However, more research is required to design effective and reproducible means to develop targeting strategies to modulate the immune response. Cow's milk proteins cause allergic symptoms in 2-3% of all infants. In these individuals, the tolerogenic state of the intestinal immune system is broken, which can lead to sensitization against antigens and eventually to allergic responses. Although a true treatment for food allergy is not available, symptoms can be avoided by providing the infants with hydrolyzed proteins. Hydrolyzed proteins are proteins that are enzymatically degraded. They lack typical allergenic IgE-binding epitopes but are also thought to play a pertinent role in other mechanisms inducing hypoallergenic effects. This review discusses the mechanisms and evidence for immunomodulating properties of cow's milk hydrolysates. Hydrolysates are found to strengthen the epithelial barrier, modulate T-cell differentiation, and decrease inflammation. Some studies suggest a role for hydrolysates in manipulating pathogen recognition receptors signaling as underlying mechanism. Peptides from hydrolysates have been shown to bind to TLR2 and TLR4 and influence cytokine production in epithelial cells and macrophages. Current insight suggests that hydrolysates may actively participate in modulating the immune responses in subjects with cow's milk allergy and those at risk to develop cow's milk allergy. However, more research is required to design effective and reproducible means to develop targeting strategies to modulate the immune response. Cow's milk proteins cause allergic symptoms in 2–3% of all infants. In these individuals, the tolerogenic state of the intestinal immune system is broken, which can lead to sensitization against antigens and eventually to allergic responses. Although a true treatment for food allergy is not available, symptoms can be avoided by providing the infants with hydrolyzed proteins. Hydrolyzed proteins are proteins that are enzymatically degraded. They lack typical allergenic IgE‐binding epitopes but are also thought to play a pertinent role in other mechanisms inducing hypoallergenic effects. This review discusses the mechanisms and evidence for immunomodulating properties of cow's milk hydrolysates. Hydrolysates are found to strengthen the epithelial barrier, modulate T‐cell differentiation, and decrease inflammation. Some studies suggest a role for hydrolysates in manipulating pathogen recognition receptors signaling as underlying mechanism. Peptides from hydrolysates have been shown to bind to TLR 2 and TLR 4 and influence cytokine production in epithelial cells and macrophages. Current insight suggests that hydrolysates may actively participate in modulating the immune responses in subjects with cow's milk allergy and those at risk to develop cow's milk allergy. However, more research is required to design effective and reproducible means to develop targeting strategies to modulate the immune response. |
Author | Gros, M. de Vos, P. van Neerven, R. J. J. Faas, M. M. Kiewiet, M. B. G. |
Author_xml | – sequence: 1 givenname: M. B. G. surname: Kiewiet fullname: Kiewiet, M. B. G. email: Gea Kiewiet, Section Immunoendocrinology, Pathology and Medical Biology, University Medical Center Groningen (UMCG), University of Groningen, Hanzeplein 1, EA 11, 9713 GZ Groningen, The NetherlandsTel.: +31 50 3610109Fax: +31 50 3619911, m.b.g.kiewiet@umcg.nl organization: Immunoendocrinology, Division of Medical Biology, Department of Pathology and Medical Biology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands – sequence: 2 givenname: M. surname: Gros fullname: Gros, M. organization: FrieslandCampina, Amersfoort, The Netherlands – sequence: 3 givenname: R. J. J. surname: van Neerven fullname: van Neerven, R. J. J. organization: FrieslandCampina, Amersfoort, The Netherlands – sequence: 4 givenname: M. M. surname: Faas fullname: Faas, M. M. organization: Immunoendocrinology, Division of Medical Biology, Department of Pathology and Medical Biology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands – sequence: 5 givenname: P. surname: de Vos fullname: de Vos, P. organization: Immunoendocrinology, Division of Medical Biology, Department of Pathology and Medical Biology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/25692325$$D View this record in MEDLINE/PubMed |
BookMark | eNp9kU1PFTEUhhuDkQu68A-YSVyoi4G2ZzqdLglRvMkVTICoq6a37WChMx3ameD8e3u5wIJEu-nX85ycnHcP7fShtwi9JfiA5HU4KHdAKLDqBVoQEKIEDM0OWmCBWVkTxnfRXkrXGBMONXmFdimrBQXKFujXsuumPnTBTF6Nrr8qhhgGG0dnUxHazW20ri9-zyYGPyc15vc2xEINg3c6K6Ev8r8Odx9S0Tl_UyjvbbyaX6OXrfLJvnnY99Hll88Xx1_L1dnJ8vhoVWoQpCq5sU3DKk41y4c11hU02tg1MAUE2JqArjkFrmtsuKDGtACKGUuJEKAoh330cVs3t3o72TTKziVtvVe9DVOSpOas4azCOKPvn6HXYYp97m5DVYI0VVVn6t0DNa07a-QQXafiLB-HloFPW0DHkFK07RNCsNwEInMg8j6QzB4-Y7Ub76c2RuX8_4w75-3879Ly-9Hy0Si3hkuj_fNkqHgjaw6cyR-nJ_Ji9W11jsVPSeAvX5Cqkw |
CitedBy_id | crossref_primary_10_1002_mnfr_201800716 crossref_primary_10_2147_JAA_S400633 crossref_primary_10_3390_nu10070904 crossref_primary_10_3390_md17060350 crossref_primary_10_1002_fsn3_1710 crossref_primary_10_26599_FSAP_2023_9240018 crossref_primary_10_1016_j_ifset_2018_03_016 crossref_primary_10_3390_nu13082762 crossref_primary_10_1080_87559129_2019_1701010 crossref_primary_10_1177_0300060518777044 crossref_primary_10_1016_j_idairyj_2017_01_010 crossref_primary_10_21323_2618_9771_2024_7_3_466_472 crossref_primary_10_3389_fimmu_2020_604075 crossref_primary_10_1007_s40521_018_0187_z crossref_primary_10_1021_acs_jafc_5c00868 crossref_primary_10_1016_j_foodchem_2025_143714 crossref_primary_10_3390_nu11071492 crossref_primary_10_1039_C8FO00913A crossref_primary_10_1080_10408398_2016_1275519 crossref_primary_10_1111_pai_12687 crossref_primary_10_3390_nu11061399 crossref_primary_10_1186_s12866_020_01991_5 crossref_primary_10_2478_afpuc_2024_0011 crossref_primary_10_1039_D1FO03223B crossref_primary_10_21323_2618_9771_2023_6_2_224_232 crossref_primary_10_1021_acsfoodscitech_3c00423 crossref_primary_10_3390_nu15010111 crossref_primary_10_1039_C7FO01537B crossref_primary_10_1016_j_jaci_2015_07_049 crossref_primary_10_26442_26586630_2022_2_201745 crossref_primary_10_3390_nu17060938 crossref_primary_10_3389_fimmu_2021_744544 crossref_primary_10_3389_fped_2020_00440 crossref_primary_10_1016_j_intimp_2018_12_047 crossref_primary_10_3390_molecules22060949 crossref_primary_10_1021_acs_jafc_1c03330 crossref_primary_10_3390_ijms24055025 crossref_primary_10_3390_nu9070731 |
Cites_doi | 10.1007/s00394-011-0186-3 10.1016/j.idairyj.2006.06.014 10.1016/j.immuni.2013.02.015 10.1016/j.foodchem.2011.01.121 10.3181/00379727-215-44119 10.1007/s12026-012-8308-4 10.1002/dmrr.2311 10.1007/978-1-4615-1371-1_50 10.1038/nri2316 10.1038/nm1720 10.1016/S1081-1206(10)62130-8 10.1093/infdis/153.6.1108 10.1017/S0007114512004655 10.1007/s00112-003-0801-3 10.1111/j.1572-0241.2006.00667.x 10.1111/j.1600-065X.2011.01017.x 10.1007/s11010-013-1911-4 10.1136/adc.81.4.309 10.2527/jas.53953 10.1136/fn.88.1.F52 10.1016/j.ejphar.2004.07.030 10.1111/j.1365-2249.2011.04394.x 10.1016/j.biopha.2006.11.003 10.1046/j.1440-1746.2003.03032.x 10.1159/000338007 10.1007/s00394-008-0710-2 10.1073/pnas.0400171101 10.1111/all.12429 10.1002/eji.201242619 10.1016/j.pupt.2010.12.009 10.1542/peds.111.S3.1595 10.1038/nature10228 10.1159/000354028 10.1111/j.1399-3038.2010.01033.x 10.1007/s00125-010-1903-9 10.1007/s12016-004-0006-0 10.1097/ACI.0b013e328346566f 10.1016/j.peptides.2009.08.005 10.1016/j.idairyj.2011.03.014 10.1016/0167-4838(92)90085-R 10.1007/s00431-009-0955-7 10.1046/j.1365-3024.2003.00632.x 10.1126/science.1188510 10.1073/pnas.0809784106 10.1007/s00216-009-2838-1 10.1016/j.foodchem.2012.03.134 10.1016/S0091-6749(00)90184-2 10.1016/j.jaci.2009.03.041 10.1155/2012/596081 10.1038/nrgastro.2013.35 10.1038/nri2707 10.3945/jn.110.135657 10.1002/eji.200940045 10.1136/adc.59.3.236 10.2174/1381612033454892 10.1084/jem.20091925 10.1111/j.1365-2567.2006.02346.x 10.3168/jds.S0022-0302(98)75752-2 10.1271/bbb.70708 10.1016/S0140-6736(00)04259-8 10.3168/jds.2013-6758 10.1084/jem.20041257 10.1016/j.idairyj.2013.05.010 10.4049/jimmunol.166.3.1471 10.5114/ceji.2012.30798 10.1021/jf062452m |
ContentType | Journal Article |
Copyright | 2015 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd 2015 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd. Copyright © 2015 John Wiley & Sons A/S. |
Copyright_xml | – notice: 2015 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd – notice: 2015 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd. – notice: Copyright © 2015 John Wiley & Sons A/S. |
DBID | BSCLL AAYXX CITATION CGR CUY CVF ECM EIF NPM 7T5 H94 K9. NAPCQ 7X8 |
DOI | 10.1111/pai.12354 |
DatabaseName | Istex CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed Immunology Abstracts AIDS and Cancer Research Abstracts ProQuest Health & Medical Complete (Alumni) Nursing & Allied Health Premium MEDLINE - Academic |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) AIDS and Cancer Research Abstracts ProQuest Health & Medical Complete (Alumni) Nursing & Allied Health Premium Immunology Abstracts MEDLINE - Academic |
DatabaseTitleList | MEDLINE - Academic MEDLINE CrossRef AIDS and Cancer Research Abstracts |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1399-3038 |
EndPage | 217 |
ExternalDocumentID | 3662786801 25692325 10_1111_pai_12354 PAI12354 ark_67375_WNG_TLMLS09X_1 |
Genre | reviewArticle Journal Article Review |
GroupedDBID | --- .3N .GA .Y3 05W 0R~ 10A 123 1OB 1OC 29O 31~ 33P 36B 3SF 4.4 50Y 50Z 51W 51X 52M 52N 52O 52P 52R 52S 52T 52U 52V 52W 52X 53G 5HH 5LA 5VS 66C 702 7PT 8-0 8-1 8-3 8-4 8-5 8UM 930 A01 A03 A8Z AAESR AAEVG AAHHS AAKAS AANLZ AAONW AASGY AAXRX AAZKR ABCQN ABCUV ABDBF ABEML ABJNI ABPVW ABQWH ABXGK ACAHQ ACBWZ ACCFJ ACCZN ACGFS ACGOF ACMXC ACPOU ACPRK ACSCC ACXBN ACXQS ADBBV ADBTR ADEOM ADIZJ ADKYN ADMGS ADOZA ADXAS ADZCM ADZMN AEEZP AEGXH AEIGN AEIMD AENEX AEQDE AEUQT AEUYR AFBPY AFEBI AFFPM AFGKR AFPWT AFRAH AFZJQ AHBTC AHEFC AHMBA AIACR AITYG AIURR AIWBW AJBDE ALAGY ALMA_UNASSIGNED_HOLDINGS ALUQN AMBMR AMYDB AOETA ASPBG ATUGU AVWKF AZBYB AZFZN AZVAB BAFTC BDRZF BFHJK BHBCM BMXJE BROTX BRXPI BSCLL BY8 C45 CAG COF CS3 D-6 D-7 D-E D-F DC6 DCZOG DPXWK DR2 DRFUL DRMAN DRSTM DU5 EAD EAP EBC EBD EBS EJD EMB EMK EMOBN ESTFP ESX EX3 F00 F01 F04 F5P FEDTE FUBAC FZ0 G-S G.N GODZA H.X HF~ HGLYW HVGLF HZI HZ~ IHE IX1 J0M J8S K48 KBYEO LATKE LC2 LC3 LEEKS LH4 LITHE LOXES LP6 LP7 LUTES LW6 LYRES MEWTI MK4 MRFUL MRMAN MRSTM MSFUL MSMAN MSSTM MXFUL MXMAN MXSTM N04 N05 N9A NF~ O66 O9- OIG OVD P2P P2W P2X P2Z P4B P4D PALCI PQQKQ Q.N Q11 QB0 R.K RIWAO RJQFR ROL RX1 SAMSI SUPJJ SV3 TEORI TUS UB1 W8V W99 WBKPD WHWMO WIH WIJ WIK WOHZO WOW WQJ WRC WUP WVDHM WXI WXSBR XG1 YFH ZZTAW ~IA ~WT AAHQN AAIPD AAMNL AANHP AAYCA ACRPL ACUHS ACYXJ ADNMO AFWVQ ALVPJ AAYXX AEYWJ AGHNM AGQPQ AGYGG CITATION AAMMB AEFGJ AGXDD AIDQK AIDYY CGR CUY CVF ECM EIF NPM 7T5 H94 K9. NAPCQ 7X8 |
ID | FETCH-LOGICAL-c3914-7de885472c5e88b0c438cdeb35a3135b13c67237c60d792ddf33a5de21993a273 |
IEDL.DBID | DR2 |
ISSN | 0905-6157 1399-3038 |
IngestDate | Fri Jul 11 05:28:50 EDT 2025 Fri Jul 25 19:06:13 EDT 2025 Mon Jul 21 05:58:48 EDT 2025 Tue Jul 01 01:25:19 EDT 2025 Thu Apr 24 22:57:00 EDT 2025 Wed Jan 22 16:25:59 EST 2025 Wed Oct 30 09:53:15 EDT 2024 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 3 |
Keywords | hydrolysates epithelial barrier food allergy Th1/Th2 balance Toll-like receptor |
Language | English |
License | http://onlinelibrary.wiley.com/termsAndConditions#vor 2015 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c3914-7de885472c5e88b0c438cdeb35a3135b13c67237c60d792ddf33a5de21993a273 |
Notes | ark:/67375/WNG-TLMLS09X-1 istex:B577E2482AEB9C549D033C36CB6FA3EF62ACD53A ArticleID:PAI12354 ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 ObjectType-Review-3 content type line 23 |
PMID | 25692325 |
PQID | 1674918446 |
PQPubID | 105695 |
PageCount | 12 |
ParticipantIDs | proquest_miscellaneous_1675875400 proquest_journals_1674918446 pubmed_primary_25692325 crossref_primary_10_1111_pai_12354 crossref_citationtrail_10_1111_pai_12354 wiley_primary_10_1111_pai_12354_PAI12354 istex_primary_ark_67375_WNG_TLMLS09X_1 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2015-05 May 2015 2015-05-00 2015-May 20150501 |
PublicationDateYYYYMMDD | 2015-05-01 |
PublicationDate_xml | – month: 05 year: 2015 text: 2015-05 |
PublicationDecade | 2010 |
PublicationPlace | England |
PublicationPlace_xml | – name: England – name: Montpellier |
PublicationTitle | Pediatric allergy and immunology |
PublicationTitleAlternate | Pediatr Allergy Immunol |
PublicationYear | 2015 |
Publisher | Blackwell Publishing Ltd Wiley Subscription Services, Inc |
Publisher_xml | – name: Blackwell Publishing Ltd – name: Wiley Subscription Services, Inc |
References | Duan C, Huo G, Yang L, Ren D, Chen J. Comparison of sensitization between beta-lactoglobulin and its hydrolysates. Asian Pac J Allergy Immunol 2012: 30: 32-9. Lahart N, O'Callaghan Y, Aherne SA, O'Sullivan D, FitzGerald RJ, O'Brien NM. Extent of hydrolysis effects on casein hydrolysate bioactivity: evaluation using the human jurkat T cell line. Int Dairy J 2011: 21: 777-82. Cian RE, Lopez-Posadas R, Drago SR, Sanchez dMF, Martinez-Augustin O. A porphyra columbina hydrolysate upregulates IL-10 production in rat macrophages and lymphocytes through an NF-kappa B, and p38 and JNK dependent mechanism. Food Chem 2012: 134: 1982-90. Nograles KE, Zaba LC, Shemer A, et al. IL-22-producing "T22" T cells account for upregulated IL-22 in atopic dermatitis despite reduced IL-17-producing T(H)17 T cells. J Allergy Clin Immunol 2009: 123: 1244-52. Mao XY, Yang HY, Song JP, Li YH, Ren FZ. Effect of yak milk casein hydrolysate on Th1/Th2 cytokines production by murine spleen lymphocytes in vitro. J Agric Food Chem 2007: 55: 638-42. Wichers H. Immunomodulation by food: promising concept for mitigating allergic disease? Anal Bioanal Chem 2009: 395: 37-45. Yu LC. Intestinal epithelial barrier dysfunction in food hypersensitivity. J Allergy 2012: 2012: 596081. Pan DD, Wu Z, Liu J, Cao XY, Zeng XQ. Immunomodulatory and hypoallergenic properties of milk protein hydrolysates in ICR mice. J Dairy Sci 2013: 96: 4958-64. Abreu MT. Toll-like receptor signalling in the intestinal epithelium: how bacterial recognition shapes intestinal function. Nat Rev Immunol 2010: 2: 131-43. Visser JT, Lammers K, Hoogendijk A, et al. Restoration of impaired intestinal barrier function by the hydrolysed casein diet contributes to the prevention of type 1 diabetes in the diabetes-prone BioBreeding rat. Diabetologia 2010: 53: 2621-8. van Elburg R, Fetter W, Bunkers C, Heymans H. Intestinal permeability in relation to birth weight and gestational and postnatal age. Arch Dis Child 2003: 88: 52-5. Thakar M, Vogel S, Kao J, Fasano A. The vibrio cholerae-generated zonula occludens toxin (zot) N-terminal cleavage site contains a protease-activated receptor activating peptide (PAR-AP) that retains biological activity on intestinal tight junctions. Gastroenterology 2005: 128: A541. Artis D. Epithelial-cell recognition of commensal bacteria and maintenance of immune homeostasis in the gut. Nat Rev Immunol 2008: 8: 411-20. Huber S, Gagliani N, Flavell RA. Life, death, and miracles: th17 cells in the intestine. Eur J Immunol 2012: 42: 2238-45. Komai-Koma M, Jones L, Ogg G, Xu D, Liew F. TLR2 is expressed on activated T cells as a costimulatory receptor. Proc Natl Acad Sci USA 2004: 101: 3029-34. Brand PLP, Rijk-van Gent H. [Cow's milk allergy in infants: new insights]. Ned Tijdschr Geneeskd 2011: 155: A3508. Macdonald T. The mucosal immune system. Parasite Immunol 2003: 25: 235-46. Gauthier SF, Pouliot Y, Saint-Sauveur D. Immunomodulatory peptides obtained by the enzymatic hydrolysis of whey proteins. Int Dairy J 2006: 16: 1315-23. Strobel S. Understanding primary oral tolerance induction: the end of the beginning. Monatsschr Kinderheilkd 2003: 151: S10-6. Bin DK, d'Hennezel E, Ben-Shoshan M, et al. Altered T helper 17 responses in children with food allergy. Int Arch Allergy Immunol 2013: 162: 318-22. Barbara G. Mucosal barrier defects in irritable bowel syndrome. who left the door open? Am J Gastroenterol 2006: 101: 1295-8. Knipping K, van Esch BCAM, van Ieperen-van Dijk AG, et al. Enzymatic treatment of whey proteins in cow's milk results in differential inhibition of IgE-mediated mast cell activation compared to T-cell activation. Int Arch Allergy Immunol 2012: 159: 263-70. Steele L, Mayer L, Berin MC. Mucosal immunology of tolerance and allergy in the gastrointestinal tract. Immunol Res 2012: 54: 75-82. Farhadi A, Banan A, Fields J, Keshavarzian A. Intestinal barrier: an interface between health and disease. J Gastroenterol Hepatol 2003: 18: 479-97. Tang C, Inman M, van Rooijen N, et al. Th type 1-stimulating activity of lung macrophages inhibits Th2-mediated allergic airway inflammation by an IFN-gamma-dependent mechanism. J Immunol 2001: 166: 1471-81. Palomares O, Yaman G, Azkur AK, Akkoc T, Akdis M, Akdis CA. Role of treg in immune regulation of allergic diseases. Eur J Immunol 2010: 40: 1232-40. Wong K, Middleton N, Montgomery M, Dey M, Carr R. Immunostimulation of murine spleen cells by materials associated with bovine milk protein fractions. J Dairy Sci 1998: 81: 1825-32. Weaver L, Laker RM, Nelson R. Intestinal permeability in the newborn. Arch Dis Child 1984: 59: 236-41. Schulz O, Jaensson E, Persson EK, et al. Intestinal CD103+, but not CX3CR1+, antigen sampling cells migrate in lymph and serve classical dendritic cell functions. J Exp Med 2009: 206: 3101-14. Takatsu K. Cytokines involved in B-cell differentiation and their sites of action. Proc Soc Exp Biol Med 1997: 215: 121-33. Nielsen DSG, Theil PK, Larsen LB, Purup S. Effect of milk hydrolysates on inflammation markers and drug-induced transcriptional alterations in cell-based models. J Anim Sci 2012: 90: 403-5. Estrada-Reyes E, Garcia-Hernandez G, Martinez-Gimeno A, Nava-Ocampo A. Effect of extensively hydrolyzed milk formula on growth and resistance to bronchitis and atopic dermatitis in infants and toddlers. J Investig Allergol Clin Immunol 2006: 16: 183-7. Jaziri M, Miglioresamour D, Casabiancapignede M, Keddad K, Morgat J, Jolles P. Specific binding-sites on human phagocytic blood-cells for gly-leu-phe and val-glu-pro-ile-pro-tyr, immunostimulating peptides from human-milk proteins. Biochim Biophys Acta 1992: 1160: 251-61. Korhonen H, Pihlanto A. Food-derived bioactive peptides - opportunities for designing future foods. Curr Pharm Des 2003: 9: 1297-308. Ulluwishewa D, Anderson RC, McNabb WC, Moughan PJ, Wells JM, Roy NC. Regulation of tight junction permeability by intestinal bacteria and dietary components. J Nutr 2011: 141: 769-76. Kang YH, Biswas SK. Basophil-macrophage dialog in allergic inflammation. Immunity 2013: 38: 408-10. Kim H, Hwang S, Kim B, Jung K, Chung D. NKT cells play critical roles in the induction of oral tolerance by inducing regulatory T cells producing IL-10 and transforming growth factor beta, and by clonally deleting antigen-specific T cells. Immunology 2006: 118: 101-11. Ndiaye F, Tri V, Duarte J, Aluko RE, Matar C. Anti-oxidant, anti-inflammatory and immunomodulating properties of an enzymatic protein hydrolysate from yellow field pea seeds. Eur J Nutr 2012: 51: 29-37. Swiatecka D, Markiewicz LH, Wroblewska B. Pea protein hydrolysate as a factor modulating the adhesion of bacteria to enterocytes, epithelial proliferation and cytokine secretion - an in vitro study. Cent Eur J Immunol 2012: 37: 227-31. Muraro A, Werfel T, Hoffmann-Sommergruber K, et al. EAACI food allergy and anaphylaxis guidelines: diagnosis and management of food allergy. Allergy 2014: 8: 1008-25. Macfarlane A, Kon O, Smith S, et al. Basophils, eosinophils, and mast cells in atopic and nonatopic asthma and in late-phase allergic reactions in the lung and skin. J Allergy Clin Immunol 2000: 105: 99-107. Henderson TR, Hamosh M, Armand M, Mehta NR, Hamosh P. Gastric proteolysis in preterm infants fed mother's milk or formula. Adv Exp Med Biol 2001: 501: 403-8. Porta C, Rimoldi M, Raes G, et al. Tolerance and M2 (alternative) macrophage polarization are related processes orchestrated by p50 nuclear factor kappa B. Proc Natl Acad Sci USA 2009: 106: 14978-83. Sackesen C, Assa'ad A, Baena-Cagnani C, et al. Cow's milk allergy as a global challenge. Curr Opin Allergy Clin Immunol 2011: 11: 243-8. Duechs MJ, Hahn C, Benediktus E, et al. TLR agonist mediated suppression of allergic responses is associated with increased innate inflammation in the airways. Pulm Pharmacol Ther 2011: 24: 203-14. Herberth G, Daegelmann C, Roder S, et al. IL-17E but not IL-17A is associated with allergic sensitization: results from the LISA study. Pediatr Allergy Immunol 2010: 21: 1086-90. He S, Liu Z, Chen X, et al. IL-9+IL-10+T cells link immediate allergic response to late phase reaction. Clin Exp Immunol 2011: 165: 29-37. Kleinert H, Pautz A, Linker K, Schwarz P. Regulation of the expression of inducible nitric oxide synthase. Eur J Pharmacol 2004: 500: 255-66. Kneepkens CMF, Meijer Y. Clinical practice. diagnosis and treatment of cow's milk allergy. Eur J Pediatr 2009: 168: 891-6. Esplugues E, Huber S, Gagliani N, et al. Control of T(H)17 cells occurs in the small intestine. Nature 2011: 475: 514-U114. Moller NP, Scholz-Ahrens KE, Roos N, Schrezenmeir J. Bioactive peptides and proteins from foods: indication for health effects. Eur J Nutr 2008: 47: 171-82. Iskandar MM, Dauletbaev N, Kubow S, Mawji N, Lands LC. Whey protein hydrolysates decrease IL-8 secretion in lipopolysaccharide (LPS)-stimulated respiratory epithelial cells by affecting LPS binding to toll-like receptor 4. Br J Nutr 2013: 110: 58-68. Tavares TG, Spindola H, Longato G, Pintado ME, Carvalho JE, Malcata FX. Antinociceptive and anti-inflammatory effects of novel dietary protein hydrolysate produced from whey by proteases of cynara cardunculus. Int Dairy J 2013: 32: 156-62. Mayer L. Mucosal immunity. Pediatrics 2003: 111: 1595-600. Weiner HL, da Cunha AP, Quintana F, Wu H. Oral tolerance. Immunol Rev 2011: 241: 241-59. de Mejia EG, Dia VP. Lunasin and lunasin-like peptides inhibit inflammation through suppression of NF-kappa B pathway in the macrophage. Peptides 2009: 30: 2388-98. van Wijk F, Knippels L. Initiating mechanisms of food allergy: oral tolerance versus allergic sensitization. Biomed Pharmacother 2007: 61: 8-20. Langrish C, Chen Y, Blumenschein W, et al. IL-23 drives a pathogenic T cell population that induces autoimmune inflammation. J Exp Med 2005: 201: 233-40. Visser JTJ, Bos NA, Harthoorn LF, et al. Potential mechanisms explaining why hydrolyzed casein-based diets outclass single amino acid-based diets in the prevention of autoimmune diabetes in diabetes-prone BB rats. Diabetes Metab Res Rev 2012: 28: 505 2010; 53 2012; 2012 2004; 26 2003; 151 2011; 11 2008; 8 1998; 81 2013; 162 2003; 18 2009; 395 2008; 72 1999; 81 2003; 111 2012; 54 2011; 475 2011; 155 2001; 501 2012; 51 2011; 127 2010; 21 2012; 134 1984; 59 2013; 10 2002; 89 2003; 9 2013; 96 2009; 123 2009; 168 2011; 21 2011; 24 2007; 61 2012; 28 2013; 110 2009; 206 2010; 2 2014; 8 2003; 88 2011; 165 2011; 241 2004; 101 2001; 166 1997; 215 2004; 500 2010; 329 1986; 153 2006; 16 1992; 1160 2008; 14 2013; 388 2012; 37 2006; 118 2007; 55 2010; 40 2012; 30 2012; 90 2009; 30 2013; 38 2013; 32 2000; 105 2005; 201 2006; 44 2005; 128 2008; 47 2003; 25 2011; 141 2012; 159 2006; 101 2001; 357 2012; 42 2009; 106 e_1_2_12_4_1 e_1_2_12_19_1 e_1_2_12_2_1 e_1_2_12_17_1 e_1_2_12_38_1 e_1_2_12_20_1 e_1_2_12_41_1 e_1_2_12_66_1 e_1_2_12_22_1 e_1_2_12_43_1 e_1_2_12_24_1 e_1_2_12_45_1 e_1_2_12_26_1 e_1_2_12_47_1 e_1_2_12_68_1 e_1_2_12_62_1 Thakar M (e_1_2_12_18_1) 2005; 128 e_1_2_12_60_1 Wu G (e_1_2_12_64_1) 2006; 44 Estrada‐Reyes E (e_1_2_12_6_1) 2006; 16 e_1_2_12_28_1 e_1_2_12_49_1 e_1_2_12_31_1 e_1_2_12_52_1 e_1_2_12_33_1 e_1_2_12_54_1 e_1_2_12_35_1 e_1_2_12_56_1 e_1_2_12_37_1 e_1_2_12_58_1 e_1_2_12_14_1 e_1_2_12_12_1 e_1_2_12_8_1 e_1_2_12_10_1 e_1_2_12_50_1 e_1_2_12_71_1 e_1_2_12_3_1 e_1_2_12_5_1 e_1_2_12_16_1 e_1_2_12_39_1 e_1_2_12_65_1 e_1_2_12_21_1 e_1_2_12_44_1 e_1_2_12_63_1 e_1_2_12_23_1 e_1_2_12_46_1 e_1_2_12_69_1 e_1_2_12_25_1 e_1_2_12_48_1 Duan C (e_1_2_12_67_1) 2012; 30 e_1_2_12_61_1 e_1_2_12_40_1 e_1_2_12_27_1 e_1_2_12_29_1 Brand PLP (e_1_2_12_42_1) 2011; 155 e_1_2_12_30_1 e_1_2_12_53_1 e_1_2_12_32_1 e_1_2_12_55_1 e_1_2_12_34_1 e_1_2_12_57_1 e_1_2_12_36_1 e_1_2_12_59_1 e_1_2_12_15_1 e_1_2_12_13_1 e_1_2_12_11_1 e_1_2_12_72_1 e_1_2_12_7_1 e_1_2_12_51_1 e_1_2_12_70_1 e_1_2_12_9_1 |
References_xml | – reference: Palomares O, Yaman G, Azkur AK, Akkoc T, Akdis M, Akdis CA. Role of treg in immune regulation of allergic diseases. Eur J Immunol 2010: 40: 1232-40. – reference: Schulz O, Jaensson E, Persson EK, et al. Intestinal CD103+, but not CX3CR1+, antigen sampling cells migrate in lymph and serve classical dendritic cell functions. J Exp Med 2009: 206: 3101-14. – reference: Barbara G. Mucosal barrier defects in irritable bowel syndrome. who left the door open? Am J Gastroenterol 2006: 101: 1295-8. – reference: Oseguera-Toledo ME, Gonzalez dME, Dia VP, Amaya-Llano SL. Common bean (Phaseolus vulgaris L.) hydrolysates inhibit inflammation in LPS-induced macrophages through suppression of NF-kappa B pathways. Food Chem 2011: 127: 1175-85. – reference: Estrada-Reyes E, Garcia-Hernandez G, Martinez-Gimeno A, Nava-Ocampo A. Effect of extensively hydrolyzed milk formula on growth and resistance to bronchitis and atopic dermatitis in infants and toddlers. J Investig Allergol Clin Immunol 2006: 16: 183-7. – reference: Macfarlane A, Kon O, Smith S, et al. Basophils, eosinophils, and mast cells in atopic and nonatopic asthma and in late-phase allergic reactions in the lung and skin. J Allergy Clin Immunol 2000: 105: 99-107. – reference: Kneepkens CMF, Meijer Y. Clinical practice. diagnosis and treatment of cow's milk allergy. Eur J Pediatr 2009: 168: 891-6. – reference: Henderson TR, Hamosh M, Armand M, Mehta NR, Hamosh P. Gastric proteolysis in preterm infants fed mother's milk or formula. Adv Exp Med Biol 2001: 501: 403-8. – reference: Terracciano L, Isoardi P, Arrigoni S, Zoja A, Martelli A. Use of hydrolysates in the treatment of cow's milk allergy. Ann Allergy Asthma Immunol 2002: 89: 86-90. – reference: Langrish C, Chen Y, Blumenschein W, et al. IL-23 drives a pathogenic T cell population that induces autoimmune inflammation. J Exp Med 2005: 201: 233-40. – reference: Yu LC. Intestinal epithelial barrier dysfunction in food hypersensitivity. J Allergy 2012: 2012: 596081. – reference: Weiner HL, da Cunha AP, Quintana F, Wu H. Oral tolerance. Immunol Rev 2011: 241: 241-59. – reference: Muraro A, Werfel T, Hoffmann-Sommergruber K, et al. EAACI food allergy and anaphylaxis guidelines: diagnosis and management of food allergy. Allergy 2014: 8: 1008-25. – reference: Ndiaye F, Tri V, Duarte J, Aluko RE, Matar C. Anti-oxidant, anti-inflammatory and immunomodulating properties of an enzymatic protein hydrolysate from yellow field pea seeds. Eur J Nutr 2012: 51: 29-37. – reference: Wu G, Tsai G. Immunomodulatory effects of oral administration of chitosan hydrolysate in BALB/c mice. Taiwanese J Agricult Chem Food Sci 2006: 44: 228-34. – reference: Nograles KE, Zaba LC, Shemer A, et al. IL-22-producing "T22" T cells account for upregulated IL-22 in atopic dermatitis despite reduced IL-17-producing T(H)17 T cells. J Allergy Clin Immunol 2009: 123: 1244-52. – reference: Kang YH, Biswas SK. Basophil-macrophage dialog in allergic inflammation. Immunity 2013: 38: 408-10. – reference: Pan DD, Wu Z, Liu J, Cao XY, Zeng XQ. Immunomodulatory and hypoallergenic properties of milk protein hydrolysates in ICR mice. J Dairy Sci 2013: 96: 4958-64. – reference: Jaziri M, Miglioresamour D, Casabiancapignede M, Keddad K, Morgat J, Jolles P. Specific binding-sites on human phagocytic blood-cells for gly-leu-phe and val-glu-pro-ile-pro-tyr, immunostimulating peptides from human-milk proteins. Biochim Biophys Acta 1992: 1160: 251-61. – reference: Knipping K, van Esch BCAM, van Ieperen-van Dijk AG, et al. Enzymatic treatment of whey proteins in cow's milk results in differential inhibition of IgE-mediated mast cell activation compared to T-cell activation. Int Arch Allergy Immunol 2012: 159: 263-70. – reference: Swiatecka D, Markiewicz LH, Wroblewska B. Pea protein hydrolysate as a factor modulating the adhesion of bacteria to enterocytes, epithelial proliferation and cytokine secretion - an in vitro study. Cent Eur J Immunol 2012: 37: 227-31. – reference: Iskandar MM, Dauletbaev N, Kubow S, Mawji N, Lands LC. Whey protein hydrolysates decrease IL-8 secretion in lipopolysaccharide (LPS)-stimulated respiratory epithelial cells by affecting LPS binding to toll-like receptor 4. Br J Nutr 2013: 110: 58-68. – reference: Esplugues E, Huber S, Gagliani N, et al. Control of T(H)17 cells occurs in the small intestine. Nature 2011: 475: 514-U114. – reference: He S, Liu Z, Chen X, et al. IL-9+IL-10+T cells link immediate allergic response to late phase reaction. Clin Exp Immunol 2011: 165: 29-37. – reference: Duechs MJ, Hahn C, Benediktus E, et al. TLR agonist mediated suppression of allergic responses is associated with increased innate inflammation in the airways. Pulm Pharmacol Ther 2011: 24: 203-14. – reference: Artis D. Epithelial-cell recognition of commensal bacteria and maintenance of immune homeostasis in the gut. Nat Rev Immunol 2008: 8: 411-20. – reference: Porta C, Rimoldi M, Raes G, et al. Tolerance and M2 (alternative) macrophage polarization are related processes orchestrated by p50 nuclear factor kappa B. Proc Natl Acad Sci USA 2009: 106: 14978-83. – reference: Tavares TG, Spindola H, Longato G, Pintado ME, Carvalho JE, Malcata FX. Antinociceptive and anti-inflammatory effects of novel dietary protein hydrolysate produced from whey by proteases of cynara cardunculus. Int Dairy J 2013: 32: 156-62. – reference: Nielsen DSG, Theil PK, Larsen LB, Purup S. Effect of milk hydrolysates on inflammation markers and drug-induced transcriptional alterations in cell-based models. J Anim Sci 2012: 90: 403-5. – reference: Ulluwishewa D, Anderson RC, McNabb WC, Moughan PJ, Wells JM, Roy NC. Regulation of tight junction permeability by intestinal bacteria and dietary components. J Nutr 2011: 141: 769-76. – reference: Manicassamy S, Reizis B, Ravindran R, et al. Activation of beta-catenin in dendritic cells regulates immunity versus tolerance in the intestine. Science 2010: 329: 849-53. – reference: Lahart N, O'Callaghan Y, Aherne SA, O'Sullivan D, FitzGerald RJ, O'Brien NM. Extent of hydrolysis effects on casein hydrolysate bioactivity: evaluation using the human jurkat T cell line. Int Dairy J 2011: 21: 777-82. – reference: Farhadi A, Banan A, Fields J, Keshavarzian A. Intestinal barrier: an interface between health and disease. J Gastroenterol Hepatol 2003: 18: 479-97. – reference: van Elburg R, Fetter W, Bunkers C, Heymans H. Intestinal permeability in relation to birth weight and gestational and postnatal age. Arch Dis Child 2003: 88: 52-5. – reference: Kalliomaki M, Salminen S, Arvilommi H, Kero P, Koskinen P, Isolauri E. Probiotics in primary prevention of atopic disease: a randomised placebo-controlled trial. Lancet 2001: 357: 1076-9. – reference: Sackesen C, Assa'ad A, Baena-Cagnani C, et al. Cow's milk allergy as a global challenge. Curr Opin Allergy Clin Immunol 2011: 11: 243-8. – reference: Mao XY, Yang HY, Song JP, Li YH, Ren FZ. Effect of yak milk casein hydrolysate on Th1/Th2 cytokines production by murine spleen lymphocytes in vitro. J Agric Food Chem 2007: 55: 638-42. – reference: Strobel S. Understanding primary oral tolerance induction: the end of the beginning. Monatsschr Kinderheilkd 2003: 151: S10-6. – reference: Tanabe S. Analysis of food allergen structures and development of foods for allergic patients. Biosci Biotechnol Biochem 2008: 72: 649-59. – reference: Zheng Y, Valdez PA, Danilenko DM, et al. Interleukin-22 mediates early host defense against attaching and effacing bacterial pathogens. Nat Med 2008: 14: 282-9. – reference: Kleinert H, Pautz A, Linker K, Schwarz P. Regulation of the expression of inducible nitric oxide synthase. Eur J Pharmacol 2004: 500: 255-66. – reference: Owen R, Pierce N, Apple R, Cray W. M-cell transport of vibrio-cholerae from the intestinal lumen into peyers-patches - a mechanism for antigen sampling and for microial trans-epithelial migration. J Infect Dis 1986: 153: 1108-18. – reference: Cian RE, Lopez-Posadas R, Drago SR, Sanchez dMF, Martinez-Augustin O. A porphyra columbina hydrolysate upregulates IL-10 production in rat macrophages and lymphocytes through an NF-kappa B, and p38 and JNK dependent mechanism. Food Chem 2012: 134: 1982-90. – reference: Weaver L, Laker RM, Nelson R. Intestinal permeability in the newborn. Arch Dis Child 1984: 59: 236-41. – reference: Steele L, Mayer L, Berin MC. Mucosal immunology of tolerance and allergy in the gastrointestinal tract. Immunol Res 2012: 54: 75-82. – reference: Abreu MT. Toll-like receptor signalling in the intestinal epithelium: how bacterial recognition shapes intestinal function. Nat Rev Immunol 2010: 2: 131-43. – reference: Kim H, Hwang S, Kim B, Jung K, Chung D. NKT cells play critical roles in the induction of oral tolerance by inducing regulatory T cells producing IL-10 and transforming growth factor beta, and by clonally deleting antigen-specific T cells. Immunology 2006: 118: 101-11. – reference: Visser JTJ, Bos NA, Harthoorn LF, et al. Potential mechanisms explaining why hydrolyzed casein-based diets outclass single amino acid-based diets in the prevention of autoimmune diabetes in diabetes-prone BB rats. Diabetes Metab Res Rev 2012: 28: 505-13. – reference: Moller NP, Scholz-Ahrens KE, Roos N, Schrezenmeir J. Bioactive peptides and proteins from foods: indication for health effects. Eur J Nutr 2008: 47: 171-82. – reference: Korhonen H, Pihlanto A. Food-derived bioactive peptides - opportunities for designing future foods. Curr Pharm Des 2003: 9: 1297-308. – reference: de Mejia EG, Dia VP. Lunasin and lunasin-like peptides inhibit inflammation through suppression of NF-kappa B pathway in the macrophage. Peptides 2009: 30: 2388-98. – reference: Gauthier SF, Pouliot Y, Saint-Sauveur D. Immunomodulatory peptides obtained by the enzymatic hydrolysis of whey proteins. Int Dairy J 2006: 16: 1315-23. – reference: Bin DK, d'Hennezel E, Ben-Shoshan M, et al. Altered T helper 17 responses in children with food allergy. Int Arch Allergy Immunol 2013: 162: 318-22. – reference: van Wijk F, Knippels L. Initiating mechanisms of food allergy: oral tolerance versus allergic sensitization. Biomed Pharmacother 2007: 61: 8-20. – reference: Huber S, Gagliani N, Flavell RA. Life, death, and miracles: th17 cells in the intestine. Eur J Immunol 2012: 42: 2238-45. – reference: Komai-Koma M, Jones L, Ogg G, Xu D, Liew F. TLR2 is expressed on activated T cells as a costimulatory receptor. Proc Natl Acad Sci USA 2004: 101: 3029-34. – reference: Herberth G, Daegelmann C, Roder S, et al. IL-17E but not IL-17A is associated with allergic sensitization: results from the LISA study. Pediatr Allergy Immunol 2010: 21: 1086-90. – reference: Washington N, Spensley P, Smith C, et al. Dual pH probe monitoring versus single pH probe monitoring in infants on milk feeds: the impact on diagnosis. Arch Dis Child 1999: 81: 309-12. – reference: Wong K, Middleton N, Montgomery M, Dey M, Carr R. Immunostimulation of murine spleen cells by materials associated with bovine milk protein fractions. J Dairy Sci 1998: 81: 1825-32. – reference: Macdonald T. The mucosal immune system. Parasite Immunol 2003: 25: 235-46. – reference: Brand PLP, Rijk-van Gent H. [Cow's milk allergy in infants: new insights]. Ned Tijdschr Geneeskd 2011: 155: A3508. – reference: Duan C, Huo G, Yang L, Ren D, Chen J. Comparison of sensitization between beta-lactoglobulin and its hydrolysates. Asian Pac J Allergy Immunol 2012: 30: 32-9. – reference: Jayashree B, Bibin YS, Prabhu D, et al. Increased circulatory levels of lipopolysaccharide (LPS) and zonulin signify novel biomarkers of proinflammation in patients with type 2 diabetes. Mol Cell Biochem 2013: 388: 203-10. – reference: Visser JT, Lammers K, Hoogendijk A, et al. Restoration of impaired intestinal barrier function by the hydrolysed casein diet contributes to the prevention of type 1 diabetes in the diabetes-prone BioBreeding rat. Diabetologia 2010: 53: 2621-8. – reference: Wichers H. Immunomodulation by food: promising concept for mitigating allergic disease? Anal Bioanal Chem 2009: 395: 37-45. – reference: Thakar M, Vogel S, Kao J, Fasano A. The vibrio cholerae-generated zonula occludens toxin (zot) N-terminal cleavage site contains a protease-activated receptor activating peptide (PAR-AP) that retains biological activity on intestinal tight junctions. Gastroenterology 2005: 128: A541. – reference: Johansson MEV, Sjovall H, Hansson GC. The gastrointestinal mucus system in health and disease. Nat Rev Gastroenterol Hepatol 2013: 10: 352-61. – reference: Tang C, Inman M, van Rooijen N, et al. Th type 1-stimulating activity of lung macrophages inhibits Th2-mediated allergic airway inflammation by an IFN-gamma-dependent mechanism. J Immunol 2001: 166: 1471-81. – reference: Mayer L. Mucosal immunity. Pediatrics 2003: 111: 1595-600. – reference: Gangloff S, Guenounou M. Toll-like receptors and immune response in allergic disease. Clin Rev Allergy Immunol 2004: 26: 115-25. – reference: Takatsu K. Cytokines involved in B-cell differentiation and their sites of action. Proc Soc Exp Biol Med 1997: 215: 121-33. – volume: 16 start-page: 183 year: 2006 end-page: 7 article-title: Effect of extensively hydrolyzed milk formula on growth and resistance to bronchitis and atopic dermatitis in infants and toddlers publication-title: J Investig Allergol Clin Immunol – volume: 51 start-page: 29 year: 2012 end-page: 37 article-title: Anti‐oxidant, anti‐inflammatory and immunomodulating properties of an enzymatic protein hydrolysate from yellow field pea seeds publication-title: Eur J Nutr – volume: 127 start-page: 1175 year: 2011 end-page: 85 article-title: Common bean ( L.) hydrolysates inhibit inflammation in LPS‐induced macrophages through suppression of NF‐kappa B pathways publication-title: Food Chem – volume: 59 start-page: 236 year: 1984 end-page: 41 article-title: Intestinal permeability in the newborn publication-title: Arch Dis Child – volume: 388 start-page: 203 year: 2013 end-page: 10 article-title: Increased circulatory levels of lipopolysaccharide (LPS) and zonulin signify novel biomarkers of proinflammation in patients with type 2 diabetes publication-title: Mol Cell Biochem – volume: 1160 start-page: 251 year: 1992 end-page: 61 article-title: Specific binding‐sites on human phagocytic blood‐cells for gly‐leu‐phe and val‐glu‐pro‐ile‐pro‐tyr, immunostimulating peptides from human‐milk proteins publication-title: Biochim Biophys Acta – volume: 357 start-page: 1076 year: 2001 end-page: 9 article-title: Probiotics in primary prevention of atopic disease: a randomised placebo‐controlled trial publication-title: Lancet – volume: 81 start-page: 1825 year: 1998 end-page: 32 article-title: Immunostimulation of murine spleen cells by materials associated with bovine milk protein fractions publication-title: J Dairy Sci – volume: 151 start-page: S10 year: 2003 end-page: 6 article-title: Understanding primary oral tolerance induction: the end of the beginning publication-title: Monatsschr Kinderheilkd – volume: 141 start-page: 769 year: 2011 end-page: 76 article-title: Regulation of tight junction permeability by intestinal bacteria and dietary components publication-title: J Nutr – volume: 25 start-page: 235 year: 2003 end-page: 46 article-title: The mucosal immune system publication-title: Parasite Immunol – volume: 10 start-page: 352 year: 2013 end-page: 61 article-title: The gastrointestinal mucus system in health and disease publication-title: Nat Rev Gastroenterol Hepatol – volume: 395 start-page: 37 year: 2009 end-page: 45 article-title: Immunomodulation by food: promising concept for mitigating allergic disease? publication-title: Anal Bioanal Chem – volume: 72 start-page: 649 year: 2008 end-page: 59 article-title: Analysis of food allergen structures and development of foods for allergic patients publication-title: Biosci Biotechnol Biochem – volume: 32 start-page: 156 year: 2013 end-page: 62 article-title: Antinociceptive and anti‐inflammatory effects of novel dietary protein hydrolysate produced from whey by proteases of cynara cardunculus publication-title: Int Dairy J – volume: 55 start-page: 638 year: 2007 end-page: 42 article-title: Effect of yak milk casein hydrolysate on Th1/Th2 cytokines production by murine spleen lymphocytes in vitro publication-title: J Agric Food Chem – volume: 96 start-page: 4958 year: 2013 end-page: 64 article-title: Immunomodulatory and hypoallergenic properties of milk protein hydrolysates in ICR mice publication-title: J Dairy Sci – volume: 30 start-page: 2388 year: 2009 end-page: 98 article-title: Lunasin and lunasin‐like peptides inhibit inflammation through suppression of NF‐kappa B pathway in the macrophage publication-title: Peptides – volume: 168 start-page: 891 year: 2009 end-page: 6 article-title: Clinical practice. diagnosis and treatment of cow's milk allergy publication-title: Eur J Pediatr – volume: 24 start-page: 203 year: 2011 end-page: 14 article-title: TLR agonist mediated suppression of allergic responses is associated with increased innate inflammation in the airways publication-title: Pulm Pharmacol Ther – volume: 215 start-page: 121 year: 1997 end-page: 33 article-title: Cytokines involved in B‐cell differentiation and their sites of action publication-title: Proc Soc Exp Biol Med – volume: 475 start-page: 514 year: 2011 end-page: U114 article-title: Control of T(H)17 cells occurs in the small intestine publication-title: Nature – volume: 111 start-page: 1595 year: 2003 end-page: 600 article-title: Mucosal immunity publication-title: Pediatrics – volume: 88 start-page: 52 year: 2003 end-page: 5 article-title: Intestinal permeability in relation to birth weight and gestational and postnatal age publication-title: Arch Dis Child – volume: 44 start-page: 228 year: 2006 end-page: 34 article-title: Immunomodulatory effects of oral administration of chitosan hydrolysate in BALB/c mice publication-title: Taiwanese J Agricult Chem Food Sci – volume: 61 start-page: 8 year: 2007 end-page: 20 article-title: Initiating mechanisms of food allergy: oral tolerance versus allergic sensitization publication-title: Biomed Pharmacother – volume: 159 start-page: 263 year: 2012 end-page: 70 article-title: Enzymatic treatment of whey proteins in cow's milk results in differential inhibition of IgE‐mediated mast cell activation compared to T‐cell activation publication-title: Int Arch Allergy Immunol – volume: 128 start-page: A541 year: 2005 article-title: The vibrio cholerae‐generated zonula occludens toxin (zot) N‐terminal cleavage site contains a protease‐activated receptor activating peptide (PAR‐AP) that retains biological activity on intestinal tight junctions publication-title: Gastroenterology – volume: 38 start-page: 408 year: 2013 end-page: 10 article-title: Basophil‐macrophage dialog in allergic inflammation publication-title: Immunity – volume: 8 start-page: 411 year: 2008 end-page: 20 article-title: Epithelial‐cell recognition of commensal bacteria and maintenance of immune homeostasis in the gut publication-title: Nat Rev Immunol – volume: 123 start-page: 1244 year: 2009 end-page: 52 article-title: IL‐22‐producing “T22” T cells account for upregulated IL‐22 in atopic dermatitis despite reduced IL‐17‐producing T(H)17 T cells publication-title: J Allergy Clin Immunol – volume: 30 start-page: 32 year: 2012 end-page: 9 article-title: Comparison of sensitization between beta‐lactoglobulin and its hydrolysates publication-title: Asian Pac J Allergy Immunol – volume: 241 start-page: 241 year: 2011 end-page: 59 article-title: Oral tolerance publication-title: Immunol Rev – volume: 21 start-page: 1086 year: 2010 end-page: 90 article-title: IL‐17E but not IL‐17A is associated with allergic sensitization: results from the LISA study publication-title: Pediatr Allergy Immunol – volume: 11 start-page: 243 year: 2011 end-page: 8 article-title: Cow's milk allergy as a global challenge publication-title: Curr Opin Allergy Clin Immunol – volume: 118 start-page: 101 year: 2006 end-page: 11 article-title: NKT cells play critical roles in the induction of oral tolerance by inducing regulatory T cells producing IL‐10 and transforming growth factor beta, and by clonally deleting antigen‐specific T cells publication-title: Immunology – volume: 166 start-page: 1471 year: 2001 end-page: 81 article-title: Th type 1‐stimulating activity of lung macrophages inhibits Th2‐mediated allergic airway inflammation by an IFN‐gamma‐dependent mechanism publication-title: J Immunol – volume: 81 start-page: 309 year: 1999 end-page: 12 article-title: Dual pH probe monitoring versus single pH probe monitoring in infants on milk feeds: the impact on diagnosis publication-title: Arch Dis Child – volume: 54 start-page: 75 year: 2012 end-page: 82 article-title: Mucosal immunology of tolerance and allergy in the gastrointestinal tract publication-title: Immunol Res – volume: 201 start-page: 233 year: 2005 end-page: 40 article-title: IL‐23 drives a pathogenic T cell population that induces autoimmune inflammation publication-title: J Exp Med – volume: 18 start-page: 479 year: 2003 end-page: 97 article-title: Intestinal barrier: an interface between health and disease publication-title: J Gastroenterol Hepatol – volume: 134 start-page: 1982 year: 2012 end-page: 90 article-title: A porphyra columbina hydrolysate upregulates IL‐10 production in rat macrophages and lymphocytes through an NF‐kappa B, and p38 and JNK dependent mechanism publication-title: Food Chem – volume: 47 start-page: 171 year: 2008 end-page: 82 article-title: Bioactive peptides and proteins from foods: indication for health effects publication-title: Eur J Nutr – volume: 500 start-page: 255 year: 2004 end-page: 66 article-title: Regulation of the expression of inducible nitric oxide synthase publication-title: Eur J Pharmacol – volume: 89 start-page: 86 year: 2002 end-page: 90 article-title: Use of hydrolysates in the treatment of cow's milk allergy publication-title: Ann Allergy Asthma Immunol – volume: 106 start-page: 14978 year: 2009 end-page: 83 article-title: Tolerance and M2 (alternative) macrophage polarization are related processes orchestrated by p50 nuclear factor kappa B publication-title: Proc Natl Acad Sci USA – volume: 16 start-page: 1315 year: 2006 end-page: 23 article-title: Immunomodulatory peptides obtained by the enzymatic hydrolysis of whey proteins publication-title: Int Dairy J – volume: 42 start-page: 2238 year: 2012 end-page: 45 article-title: Life, death, and miracles: th17 cells in the intestine publication-title: Eur J Immunol – volume: 53 start-page: 2621 year: 2010 end-page: 8 article-title: Restoration of impaired intestinal barrier function by the hydrolysed casein diet contributes to the prevention of type 1 diabetes in the diabetes‐prone BioBreeding rat publication-title: Diabetologia – volume: 105 start-page: 99 year: 2000 end-page: 107 article-title: Basophils, eosinophils, and mast cells in atopic and nonatopic asthma and in late‐phase allergic reactions in the lung and skin publication-title: J Allergy Clin Immunol – volume: 26 start-page: 115 year: 2004 end-page: 25 article-title: Toll‐like receptors and immune response in allergic disease publication-title: Clin Rev Allergy Immunol – volume: 8 start-page: 1008 year: 2014 end-page: 25 article-title: EAACI food allergy and anaphylaxis guidelines: diagnosis and management of food allergy publication-title: Allergy – volume: 501 start-page: 403 year: 2001 end-page: 8 article-title: Gastric proteolysis in preterm infants fed mother's milk or formula publication-title: Adv Exp Med Biol – volume: 162 start-page: 318 year: 2013 end-page: 22 article-title: Altered T helper 17 responses in children with food allergy publication-title: Int Arch Allergy Immunol – volume: 153 start-page: 1108 year: 1986 end-page: 18 article-title: M‐cell transport of vibrio‐cholerae from the intestinal lumen into peyers‐patches – a mechanism for antigen sampling and for microial trans‐epithelial migration publication-title: J Infect Dis – volume: 101 start-page: 1295 year: 2006 end-page: 8 article-title: Mucosal barrier defects in irritable bowel syndrome. who left the door open? publication-title: Am J Gastroenterol – volume: 155 start-page: A3508 year: 2011 article-title: [Cow's milk allergy in infants: new insights] publication-title: Ned Tijdschr Geneeskd – volume: 329 start-page: 849 year: 2010 end-page: 53 article-title: Activation of beta‐catenin in dendritic cells regulates immunity versus tolerance in the intestine publication-title: Science – volume: 2 start-page: 131 year: 2010 end-page: 43 article-title: Toll‐like receptor signalling in the intestinal epithelium: how bacterial recognition shapes intestinal function publication-title: Nat Rev Immunol – volume: 101 start-page: 3029 year: 2004 end-page: 34 article-title: TLR2 is expressed on activated T cells as a costimulatory receptor publication-title: Proc Natl Acad Sci USA – volume: 110 start-page: 58 year: 2013 end-page: 68 article-title: Whey protein hydrolysates decrease IL‐8 secretion in lipopolysaccharide (LPS)‐stimulated respiratory epithelial cells by affecting LPS binding to toll‐like receptor 4 publication-title: Br J Nutr – volume: 28 start-page: 505 year: 2012 end-page: 13 article-title: Potential mechanisms explaining why hydrolyzed casein‐based diets outclass single amino acid‐based diets in the prevention of autoimmune diabetes in diabetes‐prone BB rats publication-title: Diabetes Metab Res Rev – volume: 40 start-page: 1232 year: 2010 end-page: 40 article-title: Role of treg in immune regulation of allergic diseases publication-title: Eur J Immunol – volume: 37 start-page: 227 year: 2012 end-page: 31 article-title: Pea protein hydrolysate as a factor modulating the adhesion of bacteria to enterocytes, epithelial proliferation and cytokine secretion – an in vitro study publication-title: Cent Eur J Immunol – volume: 21 start-page: 777 year: 2011 end-page: 82 article-title: Extent of hydrolysis effects on casein hydrolysate bioactivity: evaluation using the human jurkat T cell line publication-title: Int Dairy J – volume: 9 start-page: 1297 year: 2003 end-page: 308 article-title: Food‐derived bioactive peptides – opportunities for designing future foods publication-title: Curr Pharm Des – volume: 90 start-page: 403 year: 2012 end-page: 5 article-title: Effect of milk hydrolysates on inflammation markers and drug‐induced transcriptional alterations in cell‐based models publication-title: J Anim Sci – volume: 165 start-page: 29 year: 2011 end-page: 37 article-title: IL‐9+IL‐10+T cells link immediate allergic response to late phase reaction publication-title: Clin Exp Immunol – volume: 14 start-page: 282 year: 2008 end-page: 9 article-title: Interleukin‐22 mediates early host defense against attaching and effacing bacterial pathogens publication-title: Nat Med – volume: 2012 start-page: 596081 year: 2012 article-title: Intestinal epithelial barrier dysfunction in food hypersensitivity publication-title: J Allergy – volume: 206 start-page: 3101 year: 2009 end-page: 14 article-title: Intestinal CD103+, but not CX3CR1+, antigen sampling cells migrate in lymph and serve classical dendritic cell functions publication-title: J Exp Med – ident: e_1_2_12_47_1 doi: 10.1007/s00394-011-0186-3 – volume: 155 start-page: A3508 year: 2011 ident: e_1_2_12_42_1 article-title: [Cow's milk allergy in infants: new insights] publication-title: Ned Tijdschr Geneeskd – ident: e_1_2_12_60_1 doi: 10.1016/j.idairyj.2006.06.014 – ident: e_1_2_12_57_1 doi: 10.1016/j.immuni.2013.02.015 – ident: e_1_2_12_53_1 doi: 10.1016/j.foodchem.2011.01.121 – ident: e_1_2_12_27_1 doi: 10.3181/00379727-215-44119 – ident: e_1_2_12_29_1 doi: 10.1007/s12026-012-8308-4 – ident: e_1_2_12_48_1 doi: 10.1002/dmrr.2311 – ident: e_1_2_12_9_1 doi: 10.1007/978-1-4615-1371-1_50 – ident: e_1_2_12_8_1 doi: 10.1038/nri2316 – ident: e_1_2_12_37_1 doi: 10.1038/nm1720 – ident: e_1_2_12_7_1 doi: 10.1016/S1081-1206(10)62130-8 – ident: e_1_2_12_20_1 doi: 10.1093/infdis/153.6.1108 – ident: e_1_2_12_46_1 doi: 10.1017/S0007114512004655 – ident: e_1_2_12_25_1 doi: 10.1007/s00112-003-0801-3 – ident: e_1_2_12_30_1 doi: 10.1111/j.1572-0241.2006.00667.x – ident: e_1_2_12_22_1 doi: 10.1111/j.1600-065X.2011.01017.x – ident: e_1_2_12_17_1 doi: 10.1007/s11010-013-1911-4 – ident: e_1_2_12_10_1 doi: 10.1136/adc.81.4.309 – ident: e_1_2_12_50_1 doi: 10.2527/jas.53953 – ident: e_1_2_12_14_1 doi: 10.1136/fn.88.1.F52 – ident: e_1_2_12_54_1 doi: 10.1016/j.ejphar.2004.07.030 – volume: 44 start-page: 228 year: 2006 ident: e_1_2_12_64_1 article-title: Immunomodulatory effects of oral administration of chitosan hydrolysate in BALB/c mice publication-title: Taiwanese J Agricult Chem Food Sci – volume: 128 start-page: A541 year: 2005 ident: e_1_2_12_18_1 article-title: The vibrio cholerae‐generated zonula occludens toxin (zot) N‐terminal cleavage site contains a protease‐activated receptor activating peptide (PAR‐AP) that retains biological activity on intestinal tight junctions publication-title: Gastroenterology – ident: e_1_2_12_31_1 doi: 10.1111/j.1365-2249.2011.04394.x – ident: e_1_2_12_28_1 doi: 10.1016/j.biopha.2006.11.003 – ident: e_1_2_12_52_1 doi: 10.1046/j.1440-1746.2003.03032.x – ident: e_1_2_12_62_1 doi: 10.1159/000338007 – ident: e_1_2_12_71_1 doi: 10.1007/s00394-008-0710-2 – ident: e_1_2_12_24_1 doi: 10.1073/pnas.0400171101 – ident: e_1_2_12_3_1 doi: 10.1111/all.12429 – ident: e_1_2_12_35_1 doi: 10.1002/eji.201242619 – ident: e_1_2_12_69_1 doi: 10.1016/j.pupt.2010.12.009 – ident: e_1_2_12_13_1 doi: 10.1542/peds.111.S3.1595 – ident: e_1_2_12_36_1 doi: 10.1038/nature10228 – ident: e_1_2_12_40_1 doi: 10.1159/000354028 – ident: e_1_2_12_39_1 doi: 10.1111/j.1399-3038.2010.01033.x – ident: e_1_2_12_49_1 doi: 10.1007/s00125-010-1903-9 – ident: e_1_2_12_68_1 doi: 10.1007/s12016-004-0006-0 – ident: e_1_2_12_4_1 doi: 10.1097/ACI.0b013e328346566f – ident: e_1_2_12_55_1 doi: 10.1016/j.peptides.2009.08.005 – ident: e_1_2_12_66_1 doi: 10.1016/j.idairyj.2011.03.014 – ident: e_1_2_12_45_1 doi: 10.1016/0167-4838(92)90085-R – ident: e_1_2_12_5_1 doi: 10.1007/s00431-009-0955-7 – ident: e_1_2_12_19_1 doi: 10.1046/j.1365-3024.2003.00632.x – ident: e_1_2_12_23_1 doi: 10.1126/science.1188510 – ident: e_1_2_12_56_1 doi: 10.1073/pnas.0809784106 – ident: e_1_2_12_43_1 doi: 10.1007/s00216-009-2838-1 – ident: e_1_2_12_65_1 doi: 10.1016/j.foodchem.2012.03.134 – ident: e_1_2_12_33_1 doi: 10.1016/S0091-6749(00)90184-2 – ident: e_1_2_12_38_1 doi: 10.1016/j.jaci.2009.03.041 – ident: e_1_2_12_11_1 doi: 10.1155/2012/596081 – ident: e_1_2_12_16_1 doi: 10.1038/nrgastro.2013.35 – ident: e_1_2_12_2_1 doi: 10.1038/nri2707 – ident: e_1_2_12_15_1 doi: 10.3945/jn.110.135657 – ident: e_1_2_12_32_1 doi: 10.1002/eji.200940045 – ident: e_1_2_12_12_1 doi: 10.1136/adc.59.3.236 – ident: e_1_2_12_44_1 doi: 10.2174/1381612033454892 – volume: 16 start-page: 183 year: 2006 ident: e_1_2_12_6_1 article-title: Effect of extensively hydrolyzed milk formula on growth and resistance to bronchitis and atopic dermatitis in infants and toddlers publication-title: J Investig Allergol Clin Immunol – ident: e_1_2_12_21_1 doi: 10.1084/jem.20091925 – ident: e_1_2_12_26_1 doi: 10.1111/j.1365-2567.2006.02346.x – ident: e_1_2_12_59_1 doi: 10.3168/jds.S0022-0302(98)75752-2 – ident: e_1_2_12_41_1 doi: 10.1271/bbb.70708 – ident: e_1_2_12_70_1 doi: 10.1016/S0140-6736(00)04259-8 – ident: e_1_2_12_72_1 doi: 10.3168/jds.2013-6758 – ident: e_1_2_12_34_1 doi: 10.1084/jem.20041257 – ident: e_1_2_12_58_1 doi: 10.1016/j.idairyj.2013.05.010 – ident: e_1_2_12_61_1 doi: 10.4049/jimmunol.166.3.1471 – volume: 30 start-page: 32 year: 2012 ident: e_1_2_12_67_1 article-title: Comparison of sensitization between beta‐lactoglobulin and its hydrolysates publication-title: Asian Pac J Allergy Immunol – ident: e_1_2_12_51_1 doi: 10.5114/ceji.2012.30798 – ident: e_1_2_12_63_1 doi: 10.1021/jf062452m |
SSID | ssj0017361 |
Score | 2.2649899 |
SecondaryResourceType | review_article |
Snippet | Cow's milk proteins cause allergic symptoms in 2–3% of all infants. In these individuals, the tolerogenic state of the intestinal immune system is broken,... Cow's milk proteins cause allergic symptoms in 2-3% of all infants. In these individuals, the tolerogenic state of the intestinal immune system is broken,... |
SourceID | proquest pubmed crossref wiley istex |
SourceType | Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 206 |
SubjectTerms | Animals Cattle epithelial barrier Food allergies food allergy Humans hydrolysates Immune system Immune Tolerance Immunomodulation Intestinal Mucosa - immunology Macrophages - immunology Milk Milk Hypersensitivity - diet therapy Milk Hypersensitivity - immunology Pediatrics Protein Hydrolysates - therapeutic use Proteins Receptors, Pattern Recognition - metabolism T-Lymphocytes - immunology Th1/Th2 balance Toll-like receptor |
Title | Immunomodulating properties of protein hydrolysates for application in cow's milk allergy |
URI | https://api.istex.fr/ark:/67375/WNG-TLMLS09X-1/fulltext.pdf https://onlinelibrary.wiley.com/doi/abs/10.1111%2Fpai.12354 https://www.ncbi.nlm.nih.gov/pubmed/25692325 https://www.proquest.com/docview/1674918446 https://www.proquest.com/docview/1675875400 |
Volume | 26 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3db9MwED9Nm4R4AcZnYZsMQsBLqySO40Y8dUDZ0Doh2ESRkKL4I6Nql1RpK-j--t05H9rQkBBvlnyRHdtn_8539zPASxlkWmpy_Ys07obWRqhSuJbx8CZHjtGhouTk0XF0cBp-GovxBrxtcmEqfoj2wo00w-3XpOCpWlxR8nk66VGiJ3GBUqwWAaIvLXWUL7njSvViT6B5JGTNKkRRPO2X186iLRrW3zcBzeu41R08w7vwo-lyFW8y7a2Wqqcv_mBz_M9_ugd3akDKBtUK2oYNm9-HW6Pa5f4Avh9SBklxXhj30Fd-xuZ0f18SESsrMuaIHiY5-7k2ZTFbLwi7MkTC7IprnGG9Ln69XrDzyWzK6PmW8mz9EE6HH07eHXTr9xi6msd-2JXG9vsilIEWWFCeDnlfG7TGRcp9LpTPdSQDLnXkGRkHxmScp8LYgIIEU8RJj2AzL3L7BJgXBZk1vo2UQkhjM6W4l8XEZc89E_p-B940M5Pomqyc3syYJY3RgkOVuKHqwItWdF4xdNwk9MpNbyuRllMKaZMi-Xb8MTk5Gh199eJxgg3vNPOf1Nq8SChTA1cwWs4deN5Wox6ScyXNbbFyMgJtP9wSO_C4WjdtYwgrEUcHAv_Kzf7f-5l8Hhy6wtN_F30Gt1GvRBWFuQOby3JldxEpLdUebA323-8P95xqXAIxyA56 |
linkProvider | Wiley-Blackwell |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3fb9MwED6NTQJe-A0rDDAIAS-tkjiOG4mXCTFaaCsEnSgPyEpsZ6vaJVXaCspfz52TRhsaEuItki9KYt_F3_nuvgN4IYNMS02hf5HE7dDaCE0KdRk3bwrkGB2mVJw8HEW94_DDREx24M22Fqbih2gO3Mgy3P-aDJwOpM9Z-SKZdqjSM7wCe9TR2zlUnxvyKF9yx5bqxZ5AB0nImleI8niaWy_sRns0sT8vg5oXkavbeo5uwvftS1cZJ7POepV29K8_-Bz_96tuwY0ak7LDSoluw47N78DVYR11vwvf-lREUpwVxvX6yk_Ygo7wS-JiZUXGHNfDNGenG1MW882S4CtDMMzORccZjuvix6slO5vOZ4w6uJQnm3twfPRu_LbXrlsytDWP_bAtje12RSgDLfAi9XTIu9qgQy4S7nOR-lxHMuBSR56RcWBMxnkijA0oTzBBqHQfdvMit_vAvCjIrPFtlKaIamyWptzLYqKz554Jfb8Fr7dLo3TNV05tM-Zq67fgVCk3VS143oguKpKOy4ReuvVtJJJyRlltUqivo_dqPBgOvnjxROGDD7YKoGqDXioq1kAlRue5Bc-aYTRFiq8kuS3WTkag-4d_xRY8qBSneRgiS4TSgcCvcsv_9_dUnw777uLhv4s-hWu98XCgBv3Rx0dwHc1MVEmZB7C7Ktf2MQKnVfrE2cdvhlcRIw |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3rb9MwED-NTZr4wvtRGGAQAr60SuI4bsSniVFWaKsJNtFJSFZiO6Nql1R9CMpfz53z0IaGhPgWyRcl8d3Fv_Pd_QzwUgaZlppS_yKJ26G1EboU2jIu3pTIMTpMqTl5OIoOT8KPYzHegrd1L0zJD9FsuJFnuP81OfjcZBecfJ5MOtToGV6DnTDyumTSB58b7ihfckeW6sWewPhIyIpWiMp4mlsvLUY7NK8_r0Kal4GrW3l6N-Fb_c5lwcm0s16lHf3rDzrH__yoW3CjQqRsvzSh27Bl8zuwO6xy7nfhtE8tJMV5YdxJX_kZm9MG_oKYWFmRMcf0MMnZ941ZFLPNksArQyjMLuTGGY7r4sfrJTufzKaMzm9ZnG3uwUnv_fG7w3Z1IENb89gP29LYbleEMtACL1JPh7yrDYbjIuE-F6nPdSQDLnXkGRkHxmScJ8LYgKoEEwRK92E7L3L7EJgXBZk1vo3SFDGNzdKUe1lMZPbcM6Hvt-BNrRmlK7ZyOjRjpuqoBadKualqwYtGdF5SdFwl9Mqpt5FIFlOqaZNCfR19UMeD4eCLF48VPniv1r-q3HmpqFUDTRhD5xY8b4bRESm7kuS2WDsZgcEf_hNb8KC0m-ZhiCsRSAcCv8pp_-_vqY72--7i0b-LPoPdo4OeGvRHnx7DdfQxUVZk7sH2arG2TxA1rdKnzjt-A2NXD9s |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Immunomodulating+properties+of+protein+hydrolysates+for+application+in+cow%27s+milk+allergy&rft.jtitle=Pediatric+allergy+and+immunology&rft.au=Kiewiet%2C+M+B+G&rft.au=Gros%2C+M&rft.au=van+Neerven%2C+R+J+J&rft.au=Faas%2C+M+M&rft.date=2015-05-01&rft.eissn=1399-3038&rft.volume=26&rft.issue=3&rft.spage=206&rft_id=info:doi/10.1111%2Fpai.12354&rft_id=info%3Apmid%2F25692325&rft.externalDocID=25692325 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0905-6157&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0905-6157&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0905-6157&client=summon |